-
1
-
-
79959572435
-
Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis
-
Sjoquist, K.M., Burmeister, B.H., Smithers, B.M., Zalcberg, J.R., Simes, R.J., Barbour, A., et al., Australasian Gastro-Intestinal Trials Group. Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis. Lancet Oncol 12 (2011), 681–692.
-
(2011)
Lancet Oncol
, vol.12
, pp. 681-692
-
-
Sjoquist, K.M.1
Burmeister, B.H.2
Smithers, B.M.3
Zalcberg, J.R.4
Simes, R.J.5
Barbour, A.6
-
2
-
-
80051795703
-
Chemotherapy-induced toxicities and treatment efficacy in advanced esophageal cancer treated with neoadjuvant chemotherapy followed by surgery
-
Motoori, M., Yano, M., Yasuda, T., Miyata, H., Peng, Y.F., Yamasaki, M., et al. Chemotherapy-induced toxicities and treatment efficacy in advanced esophageal cancer treated with neoadjuvant chemotherapy followed by surgery. Esophagus 8 (2011), 81–87.
-
(2011)
Esophagus
, vol.8
, pp. 81-87
-
-
Motoori, M.1
Yano, M.2
Yasuda, T.3
Miyata, H.4
Peng, Y.F.5
Yamasaki, M.6
-
3
-
-
84938289481
-
Clinical importance of supraclavicular lymph node metastasis after neoadjuvant chemotherapy for esophageal squamous cell carcinoma
-
Miyata, H., Yamasaki, M., Miyazaki, Y., Takahashi, T., Kurokawa, Y., Nakajima, K., et al. Clinical importance of supraclavicular lymph node metastasis after neoadjuvant chemotherapy for esophageal squamous cell carcinoma. Ann Surg 262 (2014), 280–285.
-
(2014)
Ann Surg
, vol.262
, pp. 280-285
-
-
Miyata, H.1
Yamasaki, M.2
Miyazaki, Y.3
Takahashi, T.4
Kurokawa, Y.5
Nakajima, K.6
-
4
-
-
77954076632
-
The role of intestinal microbiota in the development and severity of chemotherapy-induced mucositis
-
van Vliet, M.J., Harmsen, H.J., de Bont, E.S., Tissing, W.J., The role of intestinal microbiota in the development and severity of chemotherapy-induced mucositis. PLoS Pathog, 6, 2010, e1000879.
-
(2010)
PLoS Pathog
, vol.6
, pp. e1000879
-
-
van Vliet, M.J.1
Harmsen, H.J.2
de Bont, E.S.3
Tissing, W.J.4
-
5
-
-
0025804332
-
Probiotics in human medicine
-
Fuller, R., Probiotics in human medicine. Gut 32 (1991), 439–442.
-
(1991)
Gut
, vol.32
, pp. 439-442
-
-
Fuller, R.1
-
6
-
-
0032913517
-
Probiotics, prebiotics, and synbiotics: approaches for modulating the microbial ecology of the gut
-
Collins, M.D., Gibson, G.R., Probiotics, prebiotics, and synbiotics: approaches for modulating the microbial ecology of the gut. Am J Clin Nutr 69 (1999), 1052S–1057S.
-
(1999)
Am J Clin Nutr
, vol.69
, pp. 1052S-1057S
-
-
Collins, M.D.1
Gibson, G.R.2
-
7
-
-
20144387523
-
Synbiotics reduce postoperative infectious complications: a randomized controlled trial in biliary cancer patients undergoing hepatectomy
-
Kanazawa, H., Nagino, M., Kamiya, S., Komatsu, S., Mayumi, T., Takagi, K., et al. Synbiotics reduce postoperative infectious complications: a randomized controlled trial in biliary cancer patients undergoing hepatectomy. Langenbecks Arch Surg 390 (2005), 104–113.
-
(2005)
Langenbecks Arch Surg
, vol.390
, pp. 104-113
-
-
Kanazawa, H.1
Nagino, M.2
Kamiya, S.3
Komatsu, S.4
Mayumi, T.5
Takagi, K.6
-
8
-
-
84867576168
-
Impact of perioperative administration of synbiotics in patients with esophageal cancer undergoing esophagectomy: a prospective randomized controlled trial
-
Tanaka, K., Yano, M., Motoori, M., Kishi, K., Miyashiro, I., Ohue, M., et al. Impact of perioperative administration of synbiotics in patients with esophageal cancer undergoing esophagectomy: a prospective randomized controlled trial. Surgery 152 (2012), 832–842.
-
(2012)
Surgery
, vol.152
, pp. 832-842
-
-
Tanaka, K.1
Yano, M.2
Motoori, M.3
Kishi, K.4
Miyashiro, I.5
Ohue, M.6
-
9
-
-
63949084824
-
Synbiotics decrease the incidence of septic complications in patients with severe SIRS: a preliminary report
-
Shimizu, K., Ogura, H., Goto, M., Asahara, T., Nomoto, K., Morotomi, M., et al. Synbiotics decrease the incidence of septic complications in patients with severe SIRS: a preliminary report. Dig Dis Sci 54 (2009), 1071–1078.
-
(2009)
Dig Dis Sci
, vol.54
, pp. 1071-1078
-
-
Shimizu, K.1
Ogura, H.2
Goto, M.3
Asahara, T.4
Nomoto, K.5
Morotomi, M.6
-
10
-
-
0003412927
-
TNM classification of malignant tumors
-
7th ed. Wiley-Liss New York
-
Sobin, L.H., Wittekind, C.H., TNM classification of malignant tumors. 7th ed., 2009, Wiley-Liss, New York.
-
(2009)
-
-
Sobin, L.H.1
Wittekind, C.H.2
-
11
-
-
79960549412
-
Multicenter phase I/II study of docetaxel, cisplatin and fluorouracil combination chemotherapy in patients with advanced or recurrent squamous cell carcinoma of the esophagus
-
Yamasaki, M., Miyata, H., Tanaka, K., Shiraishi, O., Motoori, M., Peng, Y.F., et al. Multicenter phase I/II study of docetaxel, cisplatin and fluorouracil combination chemotherapy in patients with advanced or recurrent squamous cell carcinoma of the esophagus. Oncology 80 (2011), 307–313.
-
(2011)
Oncology
, vol.80
, pp. 307-313
-
-
Yamasaki, M.1
Miyata, H.2
Tanaka, K.3
Shiraishi, O.4
Motoori, M.5
Peng, Y.F.6
-
12
-
-
63849243189
-
Establishment of an analytical system for the human fecal microbiota, based on reverse transcription quantitative PCR targeting of multicopy rRNA molecules
-
Matsuda, K., Tsuji, H., Asahara, T., Matsumoto, K., Takada, T., Nomoto, K., Establishment of an analytical system for the human fecal microbiota, based on reverse transcription quantitative PCR targeting of multicopy rRNA molecules. Appl Environ Microbiol 75 (2009), 1961–1969.
-
(2009)
Appl Environ Microbiol
, vol.75
, pp. 1961-1969
-
-
Matsuda, K.1
Tsuji, H.2
Asahara, T.3
Matsumoto, K.4
Takada, T.5
Nomoto, K.6
-
13
-
-
78650090945
-
Identification and quantification of viable Bifidobacterium breve strain Yakult in human faeces by using strain-specific primers and propidium monoazide
-
Fujimoto, J., Tanigawa, K., Kudo, Y., Makino, H., Watanabe, K., Identification and quantification of viable Bifidobacterium breve strain Yakult in human faeces by using strain-specific primers and propidium monoazide. J Appl Microbiol 110 (2011), 209–217.
-
(2011)
J Appl Microbiol
, vol.110
, pp. 209-217
-
-
Fujimoto, J.1
Tanigawa, K.2
Kudo, Y.3
Makino, H.4
Watanabe, K.5
-
14
-
-
12144290564
-
The value of bile replacement during external biliary drainage: an analysis of intestinal permeability, integrity, and microbiota
-
Kamiya, S., Nagino, M., Kanazawa, H., Komatsu, S., Mayumi, T., Takagi, K., et al. The value of bile replacement during external biliary drainage: an analysis of intestinal permeability, integrity, and microbiota. Ann Surg 239 (2004), 510–517.
-
(2004)
Ann Surg
, vol.239
, pp. 510-517
-
-
Kamiya, S.1
Nagino, M.2
Kanazawa, H.3
Komatsu, S.4
Mayumi, T.5
Takagi, K.6
-
15
-
-
1842536006
-
Probiotic bifidobacteria protect mice from lethal infection with Shiga toxin-producing Escherichia coli O157:H7
-
Asahara, T., Shimizu, K., Nomoto, K., Hamabata, T., Ozawa, A., Takeda, Y., Probiotic bifidobacteria protect mice from lethal infection with Shiga toxin-producing Escherichia coli O157:H7. Infect Immun 72 (2004), 2240–2247.
-
(2004)
Infect Immun
, vol.72
, pp. 2240-2247
-
-
Asahara, T.1
Shimizu, K.2
Nomoto, K.3
Hamabata, T.4
Ozawa, A.5
Takeda, Y.6
-
16
-
-
83355176617
-
Changes in human fecal microbiota due to chemotherapy analyzed by TaqMan-PCR, 454 sequencing and PCR-DGGE fingerprinting
-
Zwielehner, J., Lassl, C., Hippe, B., Pointner, A., Switzeny, O.J., Remely, M., et al. Changes in human fecal microbiota due to chemotherapy analyzed by TaqMan-PCR, 454 sequencing and PCR-DGGE fingerprinting. PLoS One, 6, 2011, e28654.
-
(2011)
PLoS One
, vol.6
, pp. e28654
-
-
Zwielehner, J.1
Lassl, C.2
Hippe, B.3
Pointner, A.4
Switzeny, O.J.5
Remely, M.6
-
17
-
-
77953610750
-
Effects of the enteral administration of Bifidobacterium breve on patients undergoing chemotherapy for pediatric malignancies
-
Wada, M., Nagata, S., Saito, M., Shimizu, T., Yamashiro, Y., Matsuki, T., et al. Effects of the enteral administration of Bifidobacterium breve on patients undergoing chemotherapy for pediatric malignancies. Support Care Cancer 18 (2010), 751–759.
-
(2010)
Support Care Cancer
, vol.18
, pp. 751-759
-
-
Wada, M.1
Nagata, S.2
Saito, M.3
Shimizu, T.4
Yamashiro, Y.5
Matsuki, T.6
-
18
-
-
42549126844
-
VSL#3 probiotic treatment reduces chemotherapy-induced diarrhea and weight loss
-
Bowen, J.M., Stringer, A.M., Gibson, R.J., Yeoh, A.S., Hannam, S., Keefe, D.M., VSL#3 probiotic treatment reduces chemotherapy-induced diarrhea and weight loss. Cancer Biol Ther 6 (2007), 1449–1454.
-
(2007)
Cancer Biol Ther
, vol.6
, pp. 1449-1454
-
-
Bowen, J.M.1
Stringer, A.M.2
Gibson, R.J.3
Yeoh, A.S.4
Hannam, S.5
Keefe, D.M.6
-
19
-
-
35348904439
-
Lactobacillus supplementation for diarrhoea related to chemotherapy of colorectal cancer: a randomised study
-
Osterlund, P., Ruotsalainen, T., Korpela, R., Saxelin, M., Ollus, A., Valta, P., et al. Lactobacillus supplementation for diarrhoea related to chemotherapy of colorectal cancer: a randomised study. Br J Cancer 97 (2007), 1028–1034.
-
(2007)
Br J Cancer
, vol.97
, pp. 1028-1034
-
-
Osterlund, P.1
Ruotsalainen, T.2
Korpela, R.3
Saxelin, M.4
Ollus, A.5
Valta, P.6
-
20
-
-
0031879722
-
Effects of glutamine supplements and radiochemotherapy on systemic immune and gut barrier function in patients with advanced esophageal cancer
-
Yoshida, S., Matsui, M., Shirouzu, Y., Fujita, H., Yamana, H., Shirouzu, K., Effects of glutamine supplements and radiochemotherapy on systemic immune and gut barrier function in patients with advanced esophageal cancer. Ann Surg 227 (1998), 485–491.
-
(1998)
Ann Surg
, vol.227
, pp. 485-491
-
-
Yoshida, S.1
Matsui, M.2
Shirouzu, Y.3
Fujita, H.4
Yamana, H.5
Shirouzu, K.6
-
21
-
-
77951750871
-
Anti-infectious activity of synbiotics in a novel mouse model of methicillin-resistant Staphylococcus aureus infection
-
Lkhagvadorj, E., Nagata, S., Wada, M., Bian, L., Wang, C., Chiba, Y., et al. Anti-infectious activity of synbiotics in a novel mouse model of methicillin-resistant Staphylococcus aureus infection. Microbiol Immunol 54 (2010), 265–275.
-
(2010)
Microbiol Immunol
, vol.54
, pp. 265-275
-
-
Lkhagvadorj, E.1
Nagata, S.2
Wada, M.3
Bian, L.4
Wang, C.5
Chiba, Y.6
-
22
-
-
15344342156
-
A prospective randomised trial of probiotics in critically ill patients
-
McNaught, C.E., Woodcock, N.P., Anderson, A.D., MacFie, J., A prospective randomised trial of probiotics in critically ill patients. Clin Nutr 24 (2005), 211–219.
-
(2005)
Clin Nutr
, vol.24
, pp. 211-219
-
-
McNaught, C.E.1
Woodcock, N.P.2
Anderson, A.D.3
MacFie, J.4
-
23
-
-
84861345919
-
Randomized study of clinical effect of enteral nutrition support during neoadjuvant chemotherapy on chemotherapy-related toxicity in patients with esophageal cancer
-
Miyata, H., Yano, M., Yasuda, T., Hamano, R., Yamasaki, M., Hou, E., et al. Randomized study of clinical effect of enteral nutrition support during neoadjuvant chemotherapy on chemotherapy-related toxicity in patients with esophageal cancer. Clin Nutr 31 (2012), 330–336.
-
(2012)
Clin Nutr
, vol.31
, pp. 330-336
-
-
Miyata, H.1
Yano, M.2
Yasuda, T.3
Hamano, R.4
Yamasaki, M.5
Hou, E.6
-
24
-
-
36048990145
-
A prospective study on the epidemiology of febrile episodes during chemotherapy-induced neutropenia in children with cancer or after hemopoietic stem cell transplantation
-
Castagnola, E., Fontana, V., Caviglia, I., Caruso, S., Faraci, M., Fioredda, F., et al. A prospective study on the epidemiology of febrile episodes during chemotherapy-induced neutropenia in children with cancer or after hemopoietic stem cell transplantation. Clin Infect Dis 45 (2007), 296–304.
-
(2007)
Clin Infect Dis
, vol.45
, pp. 296-304
-
-
Castagnola, E.1
Fontana, V.2
Caviglia, I.3
Caruso, S.4
Faraci, M.5
Fioredda, F.6
-
25
-
-
24344445873
-
Simple investigation in neutropenic individuals of the frequency of infection after chemotherapy +/- antibiotic in a number of tumours (SIGNIFICANT) trial Group. Antibacterial prophylaxis after chemotherapy for solid tumors and lymphomas
-
Cullen, M., Steven, N., Billingham, L., Gaunt, C., Hastings, M., Simmonds, P., et al. Simple investigation in neutropenic individuals of the frequency of infection after chemotherapy +/- antibiotic in a number of tumours (SIGNIFICANT) trial Group. Antibacterial prophylaxis after chemotherapy for solid tumors and lymphomas. N Engl J Med 353 (2005), 988–998.
-
(2005)
N Engl J Med
, vol.353
, pp. 988-998
-
-
Cullen, M.1
Steven, N.2
Billingham, L.3
Gaunt, C.4
Hastings, M.5
Simmonds, P.6
-
26
-
-
77951851222
-
Bacterial rRNA-targeted reverse transcription-PCR used to identify pathogens responsible for fever with neutropenia
-
Sakaguchi, S., Saito, M., Tsuji, H., Asahara, T., Takata, O., Fujimura, J., et al. Bacterial rRNA-targeted reverse transcription-PCR used to identify pathogens responsible for fever with neutropenia. J Clin Microbiol 48 (2010), 1624–1628.
-
(2010)
J Clin Microbiol
, vol.48
, pp. 1624-1628
-
-
Sakaguchi, S.1
Saito, M.2
Tsuji, H.3
Asahara, T.4
Takata, O.5
Fujimura, J.6
-
27
-
-
70349202555
-
Prevention of febrile neutropenia: use of prophylactic antibiotics
-
Cullen, M., Baijal, S., Prevention of febrile neutropenia: use of prophylactic antibiotics. Br J Cancer Suppl 1 (2009), S11–S14.
-
(2009)
Br J Cancer
, vol.Suppl 1
, pp. S11-S14
-
-
Cullen, M.1
Baijal, S.2
-
28
-
-
34447630803
-
Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial
-
Hickson, M., D'Souza, A.L., Muthu, N., Rogers, T.R., Want, S., Rajkumar, C., et al. Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial. BMJ, 335, 2007, 80.
-
(2007)
BMJ
, vol.335
, pp. 80
-
-
Hickson, M.1
D'Souza, A.L.2
Muthu, N.3
Rogers, T.R.4
Want, S.5
Rajkumar, C.6
-
29
-
-
77954424086
-
Dose-response efficacy of a proprietary probiotic formula of Lactobacillus acidophilus CL1285 and Lactobacillus casei LBC80R for antibiotic-associated diarrhea and Clostridium difficile-associated diarrhea prophylaxis in adult patients
-
Gao, X.W., Mubasher, M., Fang, C.Y., Reifer, C., Miller, L.E., Dose-response efficacy of a proprietary probiotic formula of Lactobacillus acidophilus CL1285 and Lactobacillus casei LBC80R for antibiotic-associated diarrhea and Clostridium difficile-associated diarrhea prophylaxis in adult patients. Am J Gastroenterol 105 (2010), 1636–1641.
-
(2010)
Am J Gastroenterol
, vol.105
, pp. 1636-1641
-
-
Gao, X.W.1
Mubasher, M.2
Fang, C.Y.3
Reifer, C.4
Miller, L.E.5
|